Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Receivables (2020 - 2025)

Historic Receivables for GoHealth (GOCO) over the last 6 years, with Q3 2025 value amounting to $238.9 million.

  • GoHealth's Receivables fell 7358.47% to $238.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $238.9 million, marking a year-over-year decrease of 7358.47%. This contributed to the annual value of $324.9 million for FY2024, which is 6437.83% down from last year.
  • Latest data reveals that GoHealth reported Receivables of $238.9 million as of Q3 2025, which was down 7358.47% from $226.3 million recorded in Q2 2025.
  • In the past 5 years, GoHealth's Receivables ranged from a high of $1.3 billion in Q4 2021 and a low of $213.3 million during Q1 2025
  • In the last 5 years, GoHealth's Receivables had a median value of $908.2 million in 2023 and averaged $836.1 million.
  • Its Receivables has fluctuated over the past 5 years, first soared by 716695.25% in 2021, then crashed by 7497.06% in 2025.
  • GoHealth's Receivables (Quarter) stood at $1.3 billion in 2021, then dropped by 19.04% to $1.0 billion in 2022, then fell by 11.99% to $911.9 million in 2023, then crashed by 64.38% to $324.9 million in 2024, then fell by 26.44% to $238.9 million in 2025.
  • Its last three reported values are $238.9 million in Q3 2025, $226.3 million for Q2 2025, and $213.3 million during Q1 2025.